Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Small clinic case series (knee pain): One frequently cited study involved 12 patients with knee osteoarthritis or injury who received BPC-157 injections into the knee joint
Create an account to apply for access most applications are reviewed quickly
This product is intended for laboratory research purposes only and is not approved for human or veterinary use
This formulation combines Cartalax, TB-500, and BPC-157 into a single research blend, providing researchers with a valuable tool for examining coordinated peptide signaling, pathway convergence, and complementary mechanisms involved in tissue organization and extracellular matrix regulation within controlled laboratory environments
